K-Glim-M Forte 2mg Tablet is a combination oral hypoglycemic agent containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, improving peripheral glucose uptake, and enhancing insulin sensitivity. The synergistic action of these two agents helps achieve better glycemic control in patients inadequately controlled on diet, exercise, or monotherapy. K-Glim-M Forte is prescribed as part of a comprehensive diabetes management plan, including diet and lifestyle modifications. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and conditions predisposing to hypoxia. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and hypoglycemia, particularly due to Glimepiride. Regular monitoring of blood glucose, renal function, and periodic assessment of liver enzymes is recommended during therapy. Dose adjustments should be individualized based on therapeutic response and tolerability. K-Glim-M Forte should be used under medical supervision to optimize efficacy and minimize risks associated with combination therapy in type 2 diabetes mellitus.